Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653093 · ClinicalTrials.gov registry record · NA
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
A NA study of Prostate Cancer, sponsored by University of Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 1
- Study location
NCT01653093: Active NA study of Prostate Cancer, sponsored by University of Cincinnati.
NCT01653093 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 280 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01653093, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
In standard clinical care, the prostate is imaged by magnetic resonance imaging (MRI) which is a procedure to take pictures of body structures by using a strong magnetic field and radio waves. The strength of the magnet used is expressed in the unit Tesla (T); a higher Tesla number means the magnet has stronger pull. Standard magnetic resonance imaging of the prostate uses a magnet 1.5 Tesla strong as well as a specialized endorectal coil (antenna) inserted into the body due to the limitations using an external body coil at this magnet strength. MRI using a 3 Tesla magnet has a theoretical advantage over imaging at 1.5 Tesla of creating a signal twice as strong that can be received by the antennas, resulting in better pictures. The goal of this study is to make the MRI procedure more comfortable for patients by using an external coil instead of an endorectal coil. With this study, researchers also want to help patients' health care teams, the surgeons in particular. Researchers will assess the impact of prostate MRI, without an endorectal coil, done at 3 Tesla and with an external body coil on helping doctors decide which approaches to disease therapy might be best for patients as well as correlate patients' study images with all other clinical imaging
Primary Outcome
The primary outcome in this study is the agreement in tumor staging between pathology and 3 Tesla MRI.
Conditions Studied
Interventions
- PROCEDURE 3-Tesla magnetic resonance imaging (3T MRI)
- PROCEDURE diffusion-weighted magnetic resonance imaging
- PROCEDURE dynamic contrast-enhanced magnetic resonance imaging
- PROCEDURE magnetic resonance spectroscopic imaging
Study Locations (1)
Ohio
- The Ohio State University Medical Center, Stress - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2007-09-20 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT01653093 still lists
NCT01653093 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which 3-Tesla magnetic resonance imaging (3T MRI) is the first listed.
NCT01653093 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01653093 about?
NCT01653093 is a clinical study titled "3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer". In standard clinical care, the prostate is imaged by magnetic resonance imaging (MRI) which is a procedure to take pictures of body structures by using a strong magnetic field and radio waves. The strength of the magnet used is expressed in the unit Tesla (T); a higher Tesla number means the magnet ...
What is the current status of trial NCT01653093?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2007-09-20. Estimated completion is 2026-12-31.
What conditions does trial NCT01653093 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT01653093?
The interventions under investigation include: 3-Tesla magnetic resonance imaging (3T MRI) (PROCEDURE), diffusion-weighted magnetic resonance imaging (PROCEDURE), dynamic contrast-enhanced magnetic resonance imaging (PROCEDURE), magnetic resonance spectroscopic imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01653093?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01653093 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01653093's enrollment target sits among peer trials
280 175th of 735 higher than 561 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI